Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
===========================================================================================

* Carl Morrison
* Sarabjot Pabla
* Jeffrey M. Conroy
* Mary K. Nesline
* Sean T. Glenn
* Devin Dressman
* Antonios Papanicolau-Sengos
* Blake Burgher
* Jonathan Andreas
* Vincent Giamo
* Moachun Qin
* Yirong Wang
* Felicia L. Lenzo
* Angela Omilian
* Wiam Bshara
* Matthew Zibelman
* Pooja Ghatalia
* Konstantin Dragnev
* Keisuke Shirai
* Katherine G. Madden
* Laura J. Tafe
* Neel Shah
* Deepa Kasuganti
* Luis de la Cruz-Merino
* Isabel Araujo
* Yvonne Saenger
* Margaret Bogardus
* Miguel Villalona-Calero
* Zuanel Diaz
* Roger Day
* Marcia Eisenberg
* Steven M. Anderson
* Igor Puzanov
* Lorenzo Galluzzi
* Mark Gardner
* Marc S. Ernstoff